Searched for
GLAND PHARMA EBITDA MARGIN
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...- Buy, Sell or Hold: Goldman Sachs maintains sell on Bharat Dynamics; HDFC Securities maintains buy on IndiaMART InterMESHBrokerages remain divided on two stocks. Goldman Sachs retained its 'Sell' rating on Bharat Dynamics, raising the target price marginally t...
- Tata Motors shares jump 5% on strong growth guidance. What are Nomura, other brokerages saying?Tata Motors shares rose after outlining strong growth targets, including margin expansion and cash flow improvement. Brokerages remain divi...
- India's growth story, not AI trade reversal, will drive foreign flows: Sameer DalalIndia's economic strength, not AI's decline, will drive foreign capital inflows, according to Sameer Dalal. He believes AI's market correct...
- Motilal Oswal initiates coverage on KPR Mill, 7 other textile stocks with up to 43% upside. Own any?Motilal Oswal has initiated coverage on eight textile companies, turning bullish on Gokaldas Exports, Indo Count, Arvind Fashions, Pearl Gl...
- The Adani stock Morgan Stanley thinks could benefit most from India’s infrastructure pushMorgan Stanley has initiated coverage on Adani Enterprises with an Overweight rating and a target price of Rs 3,638, implying a 23% upside....
- Stocks in news: Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, Tata MotorsIndian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRC...
- Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Beyond Jio IPO: 5 triggers Mukesh Ambani has lined up to revive Reliance shares for 44 lakh investorsReliance Industries is charting a new course to boost its stock for 44 lakh investors, moving beyond a potential Jio IPO. Billionaire Mukes...
- Buy, Sell or Hold: Citi initiates buy on Meesho; Elara Capital recommends buy on Mahindra LogisticsBrokerages are selectively backing consumer, logistics, and e-commerce firms with strong growth prospects. Citi initiates coverage on Meesh...
- Meesho shares rise 2% as Citi initiates coverage with Buy rating. Here's whyInternational brokerage Citi initiated coverage on Meesho with a 'Buy' rating, setting a target price of Rs 210 and anticipating a 23% upsi...
- Will Amber Enterprises shares rally in the near term after Oppo deal? Here’s what Nuvama, other brokerages sayAmber Enterprises’ partnership with Oppo has drawn mixed brokerage views, with Nuvama and PL Capital bullish on growth and diversification ...
- Cochin Shipyard shares fall 3% amid buzz around OFS at 8% discountCochin Shipyard shares dipped Monday following reports of a potential government Offer for Sale (OFS) at a discount. The government, aiming...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Leader's Premium: The math behind Jio Platforms' priceJio Platforms' upcoming IPO is priced at a premium, reflecting its market leadership and advanced 4G/5G network. Despite smaller revenues t...
- Nykaa aims to surpass $5 billion in goods sold by fiscal 2030Nykaa aims to surpass $5 billion in gross merchandise value by fiscal 2030, projecting a two to threefold revenue increase and four to five...
- Mobikwik shares in focus as IPO lock-in expiry frees up stake worth Rs 317 crore for tradeThe shares of the fintech platform had made a solid market debut in December, 2024, listing with nearly 59% premium over the IPO price at R...
- Telecom tower companies eye 5–6% tenancy growth on network pushTelecom tower companies anticipate strong tenancy growth of five to six percent in the coming two fiscal years. This surge is fueled by tel...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
Load More
